Abstract: An adjustable flow rate implantable shunt device for use in treating glaucoma is provided. The device comprises a tubular member having a first sealed end and an open second end which are joined by a wall. The first end is inserted into the anterior portion of the eye for receipt of aqueous humor, and the second end is fastened to the sclera of the eye. The first end of the shunt device is sealed when implanted, so that flow of aqueous humor through the device immediately after implantation is prevented. After a sufficient post-implantation period such that a fibrous capsule has formed around the shunt device, at least one perforation is made along the segment of the wall of the tubular member which is located within the anterior portion of the eye to allow aqueous humor to flow through and out of the device.

Abstract: Devices and methods for performing a temporary tarsorrhaphy are provided. One device comprises two shafts mounted in parallel on the upper and lower eyelids of an eye. The shafts are then fastened together in a reversible manner to complete the temporary tarsorrhaphy. Each device further comprises a tube which is partially implanted in a linear fashion under the eyelid such that the tube is at a subcutaneous center portion and each end of the tube projects from the eyelid. The end portions of the tube that lie outside of the eyelid are each attached to the terminal portion of a shaft having first and second ends. The procedure is repeated on the lower eyelid. The shafts are then joined together with one or removable fasteners to complete the temporary tarsorrhaphy.

Abstract: Devices and methods for performing a temporary tarsorrhaphy are provided. One device comprises two clips mounted in parallel on the upper and lower eyelids of an eye. The clips are then fastened together in a reversible manner to complete the temporary tarsorrhaphy. Each clip comprises a tube which is partially implanted in a linear fashion under the eyelid such that the tube is at a subcutaneous center portion and each end of the tube projects from the eyelid. The end portions of the tube that lie outside of the eyelid are joined together by a connecting means having first and second ends. The procedure is repeated on the lower eyelid. The connecting means are then joined together with one or more removable fasteners to complete the temporary tarsorrhaphy.

Abstract: An adjustable flow rate implantable shunt device for use in treating glaucoma is provided. The device comprises a tubular member having a first sealed end and an open second end which are joined by a wall. The first end is inserted into the anterior portion of the eye for receipt of aqueous humor, and the second end is fastened to the sclera of the eye. The first end of the shunt device is sealed when implanted, so that flow of aqueous humor through the device immediately after implantation is prevented. After a sufficient post-implantation period such that a fibrous capsule has formed around the shunt device, at least one perforation is made along the segment of the wall of the tubular member which is located within the anterior portion of the eye to allow aqueous humor to flow through and out of the device, thereby lowering intraocular pressure within the eye.